查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1908144

獸醫幹細胞療法市場規模、佔有率和趨勢分析報告：按產品、動物類型、應用、最終用途、地區和細分市場預測，2025-2033年

Veterinary Stem Cell Therapy Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

獸醫幹細胞療法市場概述

2024年全球獸醫幹細胞治療市場規模估計為1.5407億美元，預計2033年將達到3.1103億美元。

預計從 2025 年到 2033 年，該行業將以 8.62% 的複合年成長率成長。該行業正在經歷顯著成長，其促進因素包括寵物慢性病和退化性疾病發病率的增加、幹細胞治療技術的不斷進步、寵物人性化趨勢的日益成長，以及飼主越來越願意投資於先進的獸醫護理。

此外，獸醫領域對先進疾病修正治療的需求不斷成長，也為市場提供了支撐。幹細胞療法具有獨特的優勢，不僅能夠緩解臨床症狀，還能直接解決許多慢性疾病的根本原因。例如，VET CELL TECH公司正利用其自主研發的iPS細胞技術，建構強大的產品線，以推動這項變革。該公司能夠大規模生產高品質、高通量的幹細胞療法藥物，並實現無縫分銷。 VET CELL TECH正在開發針對寵物主要健康問題的再生醫學藥物，包括貓的慢性齦口炎、貓的慢性腎臟病、異位性皮膚炎、犬隻的骨關節炎以及未來可能出現的多種疾病。這些治療方法標準化、擴充性，旨在滿足實際臨床需求，填補了老年和慢性病寵物照護的關鍵空白。預計這將鼓勵更多獸醫採用幹細胞療法，從而增加市場上對先進再生醫學藥物的整體投入。

此外，將先進的、循證的再生醫學引入主流獸醫護理的努力正在顯著推動市場成長。例如，根據《印度快報》2025年6月發表的報導報道，Galant公司用於治療貓科動物嚴重疼痛疾病的幹細胞療法預計將於2026年獲得美國FDA核准。這項核准將是向前邁出的重要一步，並將證明治療方法的安全性和有效性，從而增強獸醫和寵物飼主的信心。 FDA已通過核准的幹細胞產品的上市可能會促使更多診所採用該療法，預計投資者也將增加對該領域的投資。這將反過來提高再生醫學的整體接受度，並支持該行業的發展。

此外，寵物相關支出的成長也極大地推動了該行業的發展，因為越來越多的飼主將寵物視為作家人，並願意為寵物提供先進、高品質的醫療保健服務以維護它們的健康。例如，根據美國寵物用品協會（APPA）預測，美國寵物相關支出預計將從2024年的1,519億美元增加到2025年的1,570億美元，這表明飼主持續投資於高階、先進的獸醫服務。這種不斷成長的經濟負擔直接推動了幹細胞療法等高價值治療方法的普及。雖然這些治療方法可能比傳統療法更昂貴，但它們在治療骨關節炎、發育不良和發炎性疾病等慢性疾病方面具有更優的療效。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數的趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關市場展望
  • 市場動態
  • 科技趨勢
  • 定價分析
  • 主要國家和物種的動物數量估計（2021-2024 年）
  • 產品平臺分析
  • 市場分析工具
    • 波特五力分析
    • PESTEL 分析與 SWOT 分析

第4章 獸用幹細胞療法市場：依產品分類的估算與趨勢分析

  • 獸用幹細胞療法市場：依產品分類的差異分析
  • 2021-2033年獸用幹細胞療法市場按產品分類的估算與預測
  • 自體幹細胞
  • 異體幹細胞

第5章：獸醫幹細胞療法市場：按應用分類的估算和趨勢分析

  • 獸醫幹細胞療法市場：按應用領域分類的差異分析
  • 2021-2033年獸醫幹細胞療法市場按應用領域分類的估算與預測
    • 整形外科
    • 軟組織修復
    • 其他

第6章：獸用幹細胞治療市場：依動物類型分類的估算與趨勢分析

  • 獸用幹細胞療法市場：以動物類型分類的差異分析
  • 2021-2033年按動物類型分類的獸用幹細胞療法市場估算與預測
  • 小動物
  • 大型動物

第7章：獸醫幹細胞療法市場：依最終用途分類的估算與趨勢分析

  • 獸醫幹細胞療法市場：按最終用途分類的差異分析
  • 2021-2033年獸醫幹細胞療法市場按最終用途分類的估算與預測
  • 獸醫院/動物診所
  • 獸醫教育與研究學院

第8章：獸醫幹細胞治療市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2024 年及 2033 年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

第9章 競爭情勢

  • 市場參與企業分類
    • 市場領導
    • 新興玩家
  • 市場佔有率/評估分析（2024 年，熱力圖分析）
  • 公司簡介
    • Boehringer Ingelheim International GmbH
    • Vetherapy
    • Vetstem, Inc.
    • Ardent
    • Cell Therapy Sciences
    • Medrego
    • StemcellX
    • Magellan Stem Cells
    • eQcell Inc
    • Gallant
Product Code: GVR-4-68040-831-0

Veterinary Stem Cell Therapy Market Summary

The global veterinary stem cell therapy market size was estimated at USD 154.07 million in 2024 and is projected to reach USD 311.03 million by 2033, growing at a CAGR of 8.62% from 2025 to 2033. The industry is witnessing significant growth driven by the increasing incidence of chronic and degenerative conditions in pets, continuous advancements in stem cell therapy technologies, rising pet humanization, and a greater willingness among owners to invest in advanced veterinary care.

The market is further supported by the growing demand for advanced, disease-modifying therapies in veterinary care. Stem cell-based drugs provide the unique advantage of relieving clinical symptoms as well as targeting the root cause of many chronic conditions. For instance, VET CELL TECH is helping drive this shift by building a strong pipeline using its own iPSC technology, which allows it to produce stem cell treatments on a large scale with reliable quality and smoother distribution. The company is developing regenerative therapies for major pet health problems like Feline Chronic Gingivostomatitis, chronic kidney disease in cats, atopic dermatitis in dogs, osteoarthritis, and several future conditions. Because these treatments are standardized, scalable, and designed for real clinical needs, they fill important gaps in care for older and chronically sick pets. This is expected to encourage more veterinarians to adopt stem cell therapies and increase overall spending on advanced regenerative care in the market.

In addition, initiatives undertaken to bring advanced, evidence-based regenerative therapies into mainstream veterinary care are significantly shaping market growth. For instance, according to an article published by The Indian Express, in June 2025, Gallant's stem cell therapy for a serious and painful condition in cats is expected to receive U.S. FDA approval in 2026. Getting this approval would be a big step forward, showing that the treatment is safe and truly works, which would boost confidence among veterinarians and pet owners. Once FDA-approved stem cell products become available, more clinics are likely to use them, investors may put more money into the field, and overall acceptance of regenerative treatments would grow, helping push the industry forward.

Furthermore, rising pet spending is giving a strong boost to the industry, because more pet owners now treat their animals like family and are willing to pay for advanced, high-quality medical care to keep them healthy. For instance, according to APPA, the rise in U.S. pet spending from USD 151.9 billion in 2024 to a projected USD 157 billion in 2025 shows that owners are consistently allocating more money toward premium and advanced veterinary care. This growing financial commitment directly supports the adoption of high-value treatments like stem cell therapy, which can be more expensive than traditional options but offer superior outcomes for chronic conditions such as osteoarthritis, dysplasia, and inflammatory diseases.

Global Veterinary Stem Cell Therapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary stem cell therapy market report based on product, application, animal type, end-use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Autologous stem cell
  • Allogeneic stem cell
  • Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Small Animals
  • Large Animals
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Orthopedics
  • Soft Tissue Repair
  • Other Applications
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals/Clinics
  • Veterinary Academic & Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Animal Type
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Analysis
    • 1.7.2. Model 2: Analysis
    • 1.7.3. Model 3 Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increaisng Chronic Illness in Pets
      • 3.2.1.2. Technological Advancements in Stem Cell Therapy
      • 3.2.1.3. Supportive Initiatives By Government.
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Treatment Cost
      • 3.2.2.2. Lack of Awareness
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Analysis
  • 3.5. Estimated Animal Population, By Key Species, Key Countries, 2021 - 2024
  • 3.6. Product Pipeline Analysis
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary Stem Cell Therapy Market: Product Estimates & Trend Analysis

  • 4.1. Veterinary Stem Cell Therapy Market, By Product: Segment Dashboard
  • 4.2. Veterinary Stem Cell Therapy Market, By Product Movement Analysis
  • 4.3. Veterinary Stem Cell Therapy Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
  • 4.4. Autologous Stem Cell
    • 4.4.1. Autologous Stem Cell Market Estimates And Forecasts, 2021 - 2033(USD Million)
  • 4.5. Allogeneic Stem Cell
    • 4.5.1. Allogeneic Stem Cell Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 5. Veterinary Stem Cell Therapy Market: By Application Estimates & Trend Analysis

  • 5.1. Veterinary Stem Cell Therapy Market, By Application: Segment Dashboard
  • 5.2. Veterinary Stem Cell Therapy Market, By Application Movement Analysis
  • 5.3. Veterinary Stem Cell Therapy Market Estimates & Forecasts, by Application, 2021 to 2033 (USD Million)
    • 5.3.1. Orthopedics
      • 5.3.1.1. Orthopedics Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.3.2. Soft Tissue Repair
      • 5.3.2.1. Soft Tissue Repair Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.3.3. Other Applications
      • 5.3.3.1. Other Applications Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 6. Veterinary Stem Cell Therapy Market: By Animal Type Estimates & Trend Analysis

  • 6.1. Veterinary Stem Cell Therapy Market, By Animal Type: Segment Dashboard
  • 6.2. Veterinary Stem Cell Therapy Market, By Animal Type Movement Analysis
  • 6.3. Veterinary Stem Cell Therapy Market Estimates & Forecasts, by Animal Type, 2021 to 2033 (USD Million)
  • 6.4. Small Animals
    • 6.4.1. Small Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.5. Large Animals
    • 6.5.1. Large Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 7. Veterinary Stem Cell Therapy Market: By End Use Estimates & Trend Analysis

  • 7.1. Veterinary Stem Cell Therapy Market, By End Use: Segment Dashboard
  • 7.2. Veterinary Stem Cell Therapy Market, By End Use Movement Analysis
  • 7.3. Veterinary Stem Cell Therapy Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Veterinary Hospitals/Clinics
    • 7.4.1. Veterinary Hospitals/Clinics Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.5. Veterinary Academic & Research Institutes
    • 7.5.1. Veterinary Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 8. Veterinary Stem Cell Therapy Market: By Regional Estimates & Trend Analysis

  • 8.1. Region Market Dashboard
  • 8.2. Region Market Share Analysis, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Qatar
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Oman
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Boehringer Ingelheim International GmbH
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Vetherapy
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Vetstem, Inc.
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Ardent
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Cell Therapy Sciences
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Medrego
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. StemcellX
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Magellan Stem Cells
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. eQcell Inc
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Gallant
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 6 Global Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 9 North America Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 10 North America Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 11 North America Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 12 U.S. Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 13 U.S. Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 14 U.S. Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 15 U.S. Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Canada Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 17 Canada Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 18 Canada Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 19 Canada Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 20 Mexico Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 21 Mexico Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 22 Mexico Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 23 Mexico Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 24 Europe Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 25 Europe Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 26 Europe Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 27 Europe Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 28 Europe Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 29 UK Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 30 UK Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 31 UK Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 32 UK Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 33 Germany Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 34 Germany Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 35 Germany Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 36 Germany Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 37 France Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 38 France Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 39 France Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 40 France Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Italy Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 42 Italy Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 43 Italy Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 44 Italy Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 45 Spain Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 46 Spain Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 47 Spain Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 48 Spain Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 49 Denmark Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 50 Denmark Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 51 Denmark Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 52 Denmark Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 53 Sweden Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 54 Sweden Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 55 Sweden Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 56 Sweden Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 57 Norway Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 58 Norway Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 59 Norway Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 60 Norway Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 66 Japan Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 67 Japan Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 68 Japan Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 69 Japan Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 70 China Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 71 China Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 72 China Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 73 China Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 74 India Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 75 India Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 76 India Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 77 India Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 78 Australia Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 79 Australia Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 80 Australia Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 81 Australia Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 82 Thailand Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 83 Thailand Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 84 Thailand Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 85 Thailand Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 86 South Korea Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 87 South Korea Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 88 South Korea Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 89 South Korea Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 90 Latin America Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 92 Latin America Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 93 Latin America Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 94 Latin America Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 95 Brazil Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 96 Brazil Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 97 Brazil Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 98 Brazil Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 99 Argentina Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 100 Argentina Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 101 Argentina Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 102 Argentina Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 103 Middle East & Africa Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 108 South Africa Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 109 South Africa Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 110 South Africa Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 111 South Africa Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 112 UAE Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 113 UAE Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 114 UAE Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 115 UAE Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 117 Saudi Arabia Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 118 Saudi Arabia Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 119 Saudi Arabia Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 124 Qatar Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 125 Qatar Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 126 Qatar Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 127 Qatar Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 128 Oman Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
  • Table 129 Oman Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Application, 2021 - 2033 (USD Million)
  • Table 130 Oman Veterinary Stem Cell Therapy Market Estimates and Forecasts, by Animal Type, 2021 - 2033 (USD Million)
  • Table 131 Oman Veterinary Stem Cell Therapy Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Commodity Flow Analysis
  • Fig. 7 Value Chain-Based Sizing & Forecasting
  • Fig. 8 QFD Model Sizing & Forecasting
  • Fig. 9 Bottom-Up Approach
  • Fig. 10 Market Snapshot
  • Fig. 11 Segment Snapshot 1
  • Fig. 12 Segment Snapshot 2
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent Market Outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary Market Outlook, 2024 (USD Billion)
  • Fig. 16 Veterinary Stem Cell Therapy Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Veterinary Stem Cell Therapy Market: Product Outlook And Key Takeaways
  • Fig. 20 Veterinary Stem Cell Therapy Market: Product Movement Analysis
  • Fig. 21 Autologous Stem Cell Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Allogeneic Stem Cell Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Veterinary Stem Cell Therapy Market: Application Outlook And Key Takeaways
  • Fig. 24 Veterinary Stem Cell Therapy Market: Application Movement Analysis
  • Fig. 25 Orthopedics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Soft Tissue Repair Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Other Applications Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Veterinary Stem Cell Therapy Market: Animal Type Outlook And Key Takeaways
  • Fig. 29 Veterinary Stem Cell Therapy Market: Animal Type Movement Analysis
  • Fig. 30 Small Animals Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Large Animals Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Veterinary Stem Cell Therapy Market: End Use Outlook And Key Takeaways
  • Fig. 33 Veterinary Stem Cell Therapy Market: End Use Movement Analysis
  • Fig. 34 Veterinary Hospitals/Clinics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Veterinary Academic & Research Institutes Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 North America Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021-2033 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 U.S. Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Canada Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Mexico Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Europe Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 UK Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Germany Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 France Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Italy Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Spain Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Denmark Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Sweden Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Norway Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Asia Pacific Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Japan Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 China Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 India Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Australia Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Thailand Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 South Korea Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Latin America Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Brazil Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Argentina Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 MEA Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 South Africa Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 UAE Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Saudi Arabia Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Kuwait Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Qatar Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Oman Veterinary Stem Cell Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)